首页> 外文期刊>Biochemistry (Moscow). Supplement, Series A. Membrane and cell biology >β-Adrenoreceptor agonists and antagonists modulate the activity of α_2-adrenoreceptors in rat cortex cerebral membranes
【24h】

β-Adrenoreceptor agonists and antagonists modulate the activity of α_2-adrenoreceptors in rat cortex cerebral membranes

机译:β-肾上腺素受体激动剂和拮抗剂调节大鼠皮层脑膜中α_2-肾上腺素受体的活性

获取原文
获取原文并翻译 | 示例
       

摘要

The influence of isoprenaline- and propranolole-induced activation and inhibition of β-adrenoreceptors on the specific nonselective α_2-antagonist [~3H]RX821002 binding was studied on rat cerebral cortex subcellular membrane fractions. It was shown that the ligand-receptor interaction for α_2-adrenoreceptors corresponded to the model that assumed the presence of one receptor pool and binding of two ligand molecules to a receptor dimer. The following parameters were determined for [~3H]RX821002 binding to α_2-adrenoreceptors: K _(d1) = 1.57 ± 0.27 nM, B _(max) = 7.24 ± 1.63 fmol/mg of protein, n = 2. In the case of isoprenaline-induced activation of β-adrenoreceptors the binding of radiolabeled ligand to α_2-adrenoreceptors was described by the same model. The affinity of α_2-adrenoreceptors for [3H]RX821002 decreased more than twofold (K _d = 3.55 ± 0.02 nM) and the quantity of active receptors increased by 69% (B _(max) = 12.24 ± 0.06 fmol/mg of protein). Propranolole changed the model of ligand binding, and two pools of receptors were detected with the following parameters: K _(d1) = 0.61 ± 0.02 nM, K _(d2) = 3.41 ± 0.13 nM, B _(ml) = 1.88 ± 0.028 fmol/mg of protein, B _(m2) = 9.27 ± 0.08 fmol/mg of protein, n = 2. The data suggest that α_2-adrenoreceptors in subcellular membrane fractions from rat cerebral cortex exist in dimeric form. Isoprenaline and propranolole exhibit modulating effect on the specific antagonist binding to α_2- adrenoreceptors, which results in the inhibition and alteration of [ 3H]RX821002 binding parameters.
机译:研究了大鼠大脑皮质亚细胞膜组分上异丙肾上腺素和普萘洛尔诱导的激活和β-肾上腺素受体抑制对特异性非选择性α_2-拮抗剂[〜3H] RX821002结合的影响。结果表明,α_2-肾上腺素受体的配体-受体相互作用对应于假设存在一个受体池和两个配体分子与一个受体二聚体结合的模型。确定[〜3H] RX821002与α_2-肾上腺素受体结合的以下参数:K _(d1)= 1.57±0.27 nM,B _(max)= 7.24±1.63 fmol / mg蛋白质,n = 2。异丙肾上腺素诱导的β-肾上腺素受体激活的过程用同一模型描述了放射性标记的配体与α_2-肾上腺素受体的结合。 α_2-肾上腺素受体对[3H] RX821002的亲和力下降两倍以上(K _d = 3.55±0.02 nM),活性受体数量增加69%(B _(max)= 12.24±0.06 fmol / mg蛋白质) 。普萘洛尔改变了配体结合的模型,并用以下参数检测了两个受体库:K_(d1)= 0.61±0.02 nM,K_(d2)= 3.41±0.13 nM,B_(ml)= 1.88± 0.028 fmol / mg蛋白质,B_(m2)= 9.27±0.08 fmol / mg蛋白质,n =2。数据表明,大鼠大脑皮层亚细胞膜组分中的α_2-肾上腺素受体以二聚体形式存在。异丙肾上腺素和普萘洛尔对特异性拮抗剂与α_2-肾上腺素受体的结合表现出调节作用,这导致[3 H] RX821002结合参数的抑制和改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号